Indications • congitive affections due to organic impairments of the brain (including consequences of neuro-infections and craniocerebral traumas) and neurotic disturbances; • schizophrenia with a cerebral organic insufficiency ; • • cerebrovascular insufficiency due to aterosclerotic changes of the brain; • extrapyramid hyper-kinesises (myoclonus epilepsy, Huntingtone's chorea, hepato-lenticular degeneration, Parkinson's disease etc.), for treatment of the extrapyramid syndrome due to a neuroleptics use; • epilepsy with deceleration of psychic processes and a decrease of a cognitive productivity (in combination with anti-convulsive drugs); • psycho-emotional overloads, a decrease of the mental and physical workability, for an improvement of an attention concentration and memorization; • neurogenous disturbances of urination (pollakiuria, imperative feelings of urination, imperative urinary incontinence, enuresis); • children with a perinatal encephalopathy; mental retardation of a different severity (including that with behavioral disturbances); psychology state affections in children, like a common psychic development retardation, specific speech disturbances, motoric functions and combined states; hyperkinetic disturbances, including a hyperactivity syndrome with an attention deficiency; neurosis-like states (stammering (preferably a clonic form), tics).